BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11210817)

  • 21. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy.
    Lange T; Bumm T; Otto S; Al-Ali HK; Kovacs I; Krug D; Köhler T; Krahl R; Niederwieser D; Deininger MW
    Haematologica; 2004 Jan; 89(1):49-57. PubMed ID: 14754606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular diagnostic tests in hematologic diseases].
    Tohda S; Nara N
    Rinsho Byori; 2001 Mar; 49(3):205-9. PubMed ID: 11307316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
    Jha CB; Kucheria K; Choudhary VP
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differences in the localization of Alu-repeats in various chromosomes of peripheral blood cells from normal donors and bone marrow cells from patients with acute leukemia].
    Filatov LV; Mamaeva SE; Tomilin NV
    Mol Gen Mikrobiol Virusol; 1988 Nov; (11):41-5. PubMed ID: 3237236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
    Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
    Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular diagnostics of promyelocytic leukaemia.
    Kocki J; Constantinou M; Cioch M; Łańcut M; Kałuzewski B; Dmoszyńska A; Wojcierowski J
    J Appl Genet; 2003; 44(4):553-6. PubMed ID: 14617837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma.
    Ahmed MS; Kroft SH; Davis NB; King DM; Cheng YC
    Leuk Res; 2008 Sep; 32(9):1476-9. PubMed ID: 18308388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood.
    Kolb EA; Pan Q; Ladanyi M; Steinherz PG
    Cancer; 2003 Dec; 98(12):2643-50. PubMed ID: 14669284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
    Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
    Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The monitoring of residual disease for chronic myelogenous leukemia patients treated with imatinib mesylate: detection of T315I mutation in ATP binding site of BCR/ABL gene].
    Miyanishi S; Umeki K; Hayashi T; Fukutsuka K; Okumura A; Kishimori C
    Rinsho Byori; 2003 Oct; 51(10):1023-9. PubMed ID: 14653203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refined quantitative fluorescent PCR of Y-chromosome DNA sequences mosaics in Turner's syndrome patients--alternative to real-time PCR.
    Vodicka R; Vrtel R; Scheinost O; Zapletalova J; Dusek L; Marie G; Santavy J
    J Biochem Biophys Methods; 2004 Aug; 60(2):151-62. PubMed ID: 15262449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A complex, four-way variant t(15;17) in acute promyelocytic leukemia.
    Yoo SJ; Seo EJ; Lee JH; Seo YH; Park PW; Ahn JY
    Cancer Genet Cytogenet; 2006 Jun; 167(2):168-71. PubMed ID: 16737919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABL1 amplification in T-cell acute lymphoblastic leukemia.
    Bernasconi P; Calatroni S; Giardini I; Inzoli A; Castagnola C; Cavigliano PM; Rocca B; Boni M; Quarna J; Zappatore R; Caresana M; Bianchessi C; Pallavicini EB; Lazzarino M
    Cancer Genet Cytogenet; 2005 Oct; 162(2):146-50. PubMed ID: 16213363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Minimal residual disease. Methodologies and clinical implications].
    Ortega M; Coll MD; Solé F; Caballín MR
    Sangre (Barc); 1999 Aug; 44(4):283-90. PubMed ID: 10589280
    [No Abstract]   [Full Text] [Related]  

  • 40. In-situ polymerase chain reaction: foundation of the technology and today's options.
    Long AA
    Eur J Histochem; 1998; 42(2):101-9. PubMed ID: 9728287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.